Literature DB >> 25971970

Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells.

Xingbo Xu1, Xiaoying Tan1, Björn Tampe2, Elisa Sanchez1, Michael Zeisberg2, Elisabeth M Zeisberg3.   

Abstract

Endothelial to mesenchymal transition (EndMT) was originally described in heart development where the endocardial endothelial cells that line the atrioventricular canal undergo an EndMT to form the endocardial mesenchymal cushion that later gives rise to the septum and mitral and tricuspid valves. In the postnatal heart specifically, endothelial cells that originate from the endocardium maintain increased susceptibility to undergo EndMT as remnants from their embryonic origin. Such EndMT involving adult coronary endothelial cells contributes to microvascular rarefaction and subsequent chronification of hypoxia in the injured heart, ultimately leading to cardiac fibrosis. Although in most endothelial beds hypoxia induces tip cell formation and sprouting angiogenesis, here we demonstrate that hypoxia is a stimulus for human coronary endothelial cells to undergo phenotypic changes reminiscent of EndMT via a mechanism involving hypoxia-inducible factor 1α-induced activation of the EndMT master regulatory transcription factor SNAIL. Our study adds further evidence for the unique susceptibility of endocardium-derived endothelial cells to undergo EndMT and provides novel insights into how hypoxia contributes to progression of cardiac fibrosis. Additional studies may be required to discriminate between distinct sprouting angiogenesis and EndMT responses of different endothelial cells populations.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  endothelial cell; fibroblast; fibrosis; hypoxia; hypoxia-inducible factor (HIF)

Mesh:

Substances:

Year:  2015        PMID: 25971970      PMCID: PMC4505417          DOI: 10.1074/jbc.M115.636944

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Angiogenic sprouting is regulated by endothelial cell expression of Slug.

Authors:  Katrina M Welch-Reardon; Seema M Ehsan; Kehui Wang; Nan Wu; Andrew C Newman; Monica Romero-Lopez; Ashley H Fong; Steven C George; Robert A Edwards; Christopher C W Hughes
Journal:  J Cell Sci       Date:  2014-02-19       Impact factor: 5.285

2.  Development of heart valves requires Gata4 expression in endothelial-derived cells.

Authors:  José Rivera-Feliciano; Kyu-Ho Lee; Sek Won Kong; Satish Rajagopal; Qing Ma; Zhangli Springer; Seigo Izumo; Clifford J Tabin; William T Pu
Journal:  Development       Date:  2006-08-16       Impact factor: 6.868

Review 3.  Molecular regulation of atrioventricular valvuloseptal morphogenesis.

Authors:  L M Eisenberg; R R Markwald
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

4.  EndMT contributes to the onset and progression of cerebral cavernous malformations.

Authors:  Luigi Maddaluno; Noemi Rudini; Roberto Cuttano; Luca Bravi; Costanza Giampietro; Monica Corada; Luca Ferrarini; Fabrizio Orsenigo; Eleanna Papa; Gwenola Boulday; Elisabeth Tournier-Lasserve; Françoise Chapon; Cristina Richichi; Saverio Francesco Retta; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  Nature       Date:  2013-06-09       Impact factor: 49.962

Review 5.  Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease.

Authors:  Jason C Kovacic; Nadia Mercader; Miguel Torres; Manfred Boehm; Valentin Fuster
Journal:  Circulation       Date:  2012-04-10       Impact factor: 29.690

6.  Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.

Authors:  Chi-Hung Huang; Wen-Hao Yang; Shyue-Yih Chang; Shyh-Kuan Tai; Cheng-Hwei Tzeng; Jung-Yie Kao; Kou-Juey Wu; Muh-Hwa Yang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo.

Authors:  Yukiko Nakano; Masahito Oyamada; Ping Dai; Takuo Nakagami; Shigeru Kinoshita; Tetsuro Takamatsu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

8.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Authors:  Elisabeth M Zeisberg; Oleg Tarnavski; Michael Zeisberg; Adam L Dorfman; Julie R McMullen; Erika Gustafsson; Anil Chandraker; Xueli Yuan; William T Pu; Anita B Roberts; Eric G Neilson; Mohamed H Sayegh; Seigo Izumo; Raghu Kalluri
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

9.  Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling.

Authors:  Bingruo Wu; Zheng Zhang; Wendy Lui; Xiangjian Chen; Yidong Wang; Alyssa A Chamberlain; Ricardo A Moreno-Rodriguez; Roger R Markwald; Brian P O'Rourke; David J Sharp; Deyou Zheng; Jack Lenz; H Scott Baldwin; Ching-Pin Chang; Bin Zhou
Journal:  Cell       Date:  2012-11-21       Impact factor: 41.582

10.  Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.

Authors:  C E Ford; S K Lau; C Q Zhu; T Andersson; M S Tsao; W F Vogel
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

View more
  69 in total

1.  M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.

Authors:  Keith Q Wu; Christopher S Muratore; Eui-Young So; Changqi Sun; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

2.  Pancreatic fibroblast exosomes regulate survival of cancer cells.

Authors:  S Suklabaidya; P Dash; S Senapati
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

3.  Angiotensin-(1-7) and the Regulation of Anti-Fibrotic Signaling Pathways.

Authors:  Mark C Chappell; Ebaa M Al Zayadneh
Journal:  J Cell Signal       Date:  2017-01-27

4.  Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways.

Authors:  Kangling Zhang; Pei Xu; James L Sowers; Daniel F Machuca; Barsam Mirfattah; Jason Herring; Hui Tang; Yan Chen; Bing Tian; Allan R Brasier; Lawrence C Sowers
Journal:  Mol Cell Proteomics       Date:  2017-09-05       Impact factor: 5.911

5.  Abrogation of transforming growth factor-β-induced tissue fibrosis in mice with a global genetic deletion of Nox4.

Authors:  Peter J Wermuth; Fabian A Mendoza; Sergio A Jimenez
Journal:  Lab Invest       Date:  2018-11-23       Impact factor: 5.662

6.  Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.

Authors:  S-H Wang; J S Chang; J-R Hsiao; Y-C Yen; S S Jiang; S-H Liu; Y-L Chen; Y-Y Shen; J-Y Chang; Y-W Chen
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

7.  Hypoxia-induced epithelial to mesenchymal transition in cancer.

Authors:  Robert Y Hapke; Scott M Haake
Journal:  Cancer Lett       Date:  2020-05-26       Impact factor: 8.679

8.  Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.

Authors:  Shi-Jiang Deng; Heng-Yu Chen; Zeng Ye; Shi-Chang Deng; Shuai Zhu; Zhu Zeng; Chi He; Ming-Liang Liu; Kang Huang; Jian-Xin Zhong; Feng-Yu Xu; Qiang Li; Yang Liu; Chun-You Wang; Gang Zhao
Journal:  Oncogene       Date:  2018-07-03       Impact factor: 9.867

Review 9.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

Review 10.  Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.